{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:02:14Z","timestamp":1768514534298,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06650-3","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:45:08Z","timestamp":1763631908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Asymmetric dimethylarginine as a predictive marker for resistance to high-dose intravenous immunoglobulin in Kawasaki disease"],"prefix":"10.1007","volume":"184","author":[{"given":"Masahiro","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Taku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Kojiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Hoshina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"6650_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapediatrics.2022.3756","volume":"176","author":"R Ae","year":"2022","unstructured":"Ae R, Makino N, Kuwabara M, Matsubara Y, Kosami K, Sasahara T et al (2022) Incidence of Kawasaki disease beforeand after the COVID-19 pandemic in Japan: results of the 26th nationwidesurvey, 2019 to 2020. JAMA Pediatr 176:1217\u201324","journal-title":"JAMA Pediatr"},{"issue":"8","key":"6650_CR2","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y, Tsuda E, Nakajima H, Matsuura H, Ikeda K, Nishigaki K, Suzuki H, Takahashi K, Suda K, Kamiyama H, Onouchi Y, Kobayashi T, Yokoi H, Sakamoto K, Ochi M, Kitamura S, Hamaoka K, Senzaki H, Kimura T, Japanese Circulation Society Joint Working Group (2020) JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J 84(8):1348\u20131407. https:\/\/doi.org\/10.1253\/circj.CJ-19-1094","journal-title":"Circ J"},{"key":"6650_CR3","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/cir.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927\u2013e999. https:\/\/doi.org\/10.1161\/cir.0000000000000484","journal-title":"Circulation"},{"key":"6650_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","volume":"225","author":"R Ae","year":"2020","unstructured":"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018. J Pediatr 225:23-29.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.034","journal-title":"J Pediatr"},{"key":"6650_CR5","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606\u20132612","journal-title":"Circulation"},{"key":"6650_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237\u2013240","journal-title":"J Pediatr"},{"key":"6650_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K et al (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131\u2013137","journal-title":"Eur J Pediatr"},{"key":"6650_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/s0735-1097(98)00033-3","volume":"31","author":"R Yamakawa","year":"1998","unstructured":"Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M et al (1998) Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 31:1074\u20131080. https:\/\/doi.org\/10.1016\/s0735-1097(98)00033-3","journal-title":"J Am Coll Cardiol"},{"key":"6650_CR9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1651-2227.2010.01875.x","volume":"99","author":"HC Kuo","year":"2010","unstructured":"Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD (2010) Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 99:1578\u20131583","journal-title":"Acta Paediatr"},{"key":"6650_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","volume":"339","author":"P Vallance","year":"1992","unstructured":"Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572\u2013575","journal-title":"Lancet"},{"key":"6650_CR11","doi-asserted-by":"publisher","first-page":"13527","DOI":"10.1073\/pnas.212269799","volume":"99","author":"J Leiper","year":"2002","unstructured":"Leiper J, Murray-Rust J, McDonald N, Vallance P (2002) S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A 99:13527\u201313532","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6650_CR12","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.2174\/13816128113199990480","volume":"20","author":"S Ueda","year":"2014","unstructured":"Ueda S, Yamagishi S, Yokoro M, Okuda S (2014) Role of asymmetric dimethylarginine in cardiorenal syndrome. Curr Pharm Des 20:2448\u20132455","journal-title":"Curr Pharm Des"},{"key":"6650_CR13","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","volume":"98","author":"RH B\u00f6ger","year":"1998","unstructured":"B\u00f6ger RH, Bode-B\u00f6ger SM, Szuba A, Tsao PS, Chan JR, Tangphao O et al (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842\u20131847","journal-title":"Circulation"},{"key":"6650_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jpeds.2014.04.031","volume":"165","author":"YH Huang","year":"2014","unstructured":"Huang YH, Tain YL, Lee CP, Kuo HC (2014) Asymmetric and symmetric dimethylarginine are associated with coronary artery lesions in Kawasaki disease. J Pediatr 165:295\u2013299","journal-title":"J Pediatr"},{"key":"6650_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","volume":"62","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T et al (2020) Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr Int 62:1135\u20131138. https:\/\/doi.org\/10.1111\/ped.14326","journal-title":"Pediatr Int"},{"key":"6650_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","volume":"99","author":"H Miyazaki","year":"1999","unstructured":"Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S et al (1999) Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99:1141\u20131146","journal-title":"Circulation"},{"key":"6650_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0021-9150(01)00444-0","volume":"158","author":"JH Yoo","year":"2001","unstructured":"Yoo JH, Lee SC (2001) Elevated levels of plasma homocysteine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158:425\u2013430","journal-title":"Atherosclerosis"},{"key":"6650_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejvs.2016.12.017","volume":"53","author":"S Senol","year":"2017","unstructured":"Senol S, Senol A (2017) Investigation of asymmetric and symmetric dimethylarginine levels after iloprost treatment in patients with Buerger\u2019s disease. Eur J Vasc Endovasc Surg 53:439\u2013442","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"6650_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/09273948.2024.2342378","volume":"33","author":"OA Sayed","year":"2025","unstructured":"Sayed OA, Abdel-Magied RA, Ahmed Abu Elela M, Safwat AM, Abdel-Nasser AM (2025) Value of serum asymmetric dimethylarginine (ADMA) as a novel biomarker for uveitis in Behcet\u2019s disease. Ocul Immunol Inflamm 33(1):33\u201339. https:\/\/doi.org\/10.1080\/09273948.2024.2342378","journal-title":"Ocul Immunol Inflamm"},{"key":"6650_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bbrc.2010.01.040","volume":"392","author":"E Straface","year":"2010","unstructured":"Straface E, Gambardella L, Metere A, Marchesi A, Palumbo G, Cortis E et al (2010) Oxidative stress and defective platelet apoptosis in na\u00efve patients with Kawasaki disease. Biochem Biophys Res Commun 392:426\u2013430","journal-title":"Biochem Biophys Res Commun"},{"key":"6650_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12872-018-0765-9","volume":"18","author":"T Ishikawa","year":"2018","unstructured":"Ishikawa T, Seki K (2018) The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease. BMC Cardiovasc Disord 18:30","journal-title":"BMC Cardiovasc Disord"},{"issue":"20","key":"6650_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015450","volume":"24","author":"M Tsuge","year":"2023","unstructured":"Tsuge M, Uda K, Eitoku T, Matsumoto N, Yorifuji T, Tsukahara H (2023) Roles of oxidative injury and nitric oxide system derangements in Kawasaki disease pathogenesis: a systematic review. Int J Mol Sci 24(20):15450. https:\/\/doi.org\/10.3390\/ijms242015450","journal-title":"Int J Mol Sci"},{"key":"6650_CR23","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1089\/ars.2012.4660","volume":"17","author":"E Straface","year":"2012","unstructured":"Straface E, Marchesi A, Gambardella L, Metere A, Tarissi de Jacobis I, Viora M et al (2012) Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease? Antioxid Redox Signal 17:1441\u20131446","journal-title":"Antioxid Redox Signal"},{"key":"6650_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00431-008-0872-1","volume":"168","author":"K Yoshimura","year":"2009","unstructured":"Yoshimura K, Tatsumi K, Iharada A, Tsuji S, Tateiwa A, Teraguchi M et al (2009) Increased nitric oxide production by neutrophils in early stage of Kawasaki disease. Eur J Pediatr 168:1037\u20131041","journal-title":"Eur J Pediatr"},{"key":"6650_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13052-025-01889-w","volume":"51","author":"S Wang","year":"2025","unstructured":"Wang S, Sun N, Liu P, Qian W, Xu Q, Yang D et al (2025) Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts. Ital J Pediatr 51:55","journal-title":"Ital J Pediatr"},{"key":"6650_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2141.2009.07922.x","volume":"148","author":"K Ueno","year":"2010","unstructured":"Ueno K, Nomura Y, Hashiguchi T, Masuda K, Morita Y, Hazeki D et al (2010) Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. Br J Haematol 148:285\u2013292","journal-title":"Br J Haematol"},{"key":"6650_CR27","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1253\/circj.CJ-14-1323","volume":"79","author":"K Ueno","year":"2015","unstructured":"Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y (2015) Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease. Circ J 79:1349\u20131356","journal-title":"Circ J"},{"key":"6650_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S2352-4642(23)00166-9","volume":"7","author":"H Wang","year":"2023","unstructured":"Wang H, Shimizu C, Bainto E, Hamilton S, Jackson HR, Estrada-Rivadeneyra D et al (2023) Subgroups of children with Kawasaki disease: a data-driven cluster analysis. Lancet Child Adolesc Health 7:697\u2013707","journal-title":"Lancet Child Adolesc Health"},{"key":"6650_CR29","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S2352-4642(21)00270-4","volume":"5","author":"JC Burns","year":"2021","unstructured":"Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N et al (2021) Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health 5:852\u2013861","journal-title":"Lancet Child Adolesc Health"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06650-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:43:43Z","timestamp":1768459423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06650-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6650"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06650-3","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Institutional Review Board of the University of Occupational and Environmental Health, Japan (UOEHCRB20-002), and of Kitakyushu General Hospital (R2-19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent to participate in this study was obtained from the patients\u2019 parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"776"}}